NOCIL Q4 FY26: Capex ₹130 Cr
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹330Cr
- −2.9% YoY
- +4.4% QoQ
- Net profit
- ₹17Cr
- −19% YoY
- +88.9% QoQ
- Margin
- 6%
- −4 pp YoY
- −2 pp QoQ
Guidance rank: #60 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
NOCIL targets double-digit volume growth for FY '27 and FY '28. NOCIL targets double-digit volume growth for FY '27 and FY '28.
From NOCIL's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- NOCIL targets double-digit volume growth for FY '27 and FY '28. (Page 18)
- Volume growth momentum picked up in H2 FY '26, expected to continue into FY '27. (Page 6)
- New plant expansions and customer approvals anticipated to drive volume increase, with material capacity utilization improvements expected 6-8 months post-sample submission. (Page 14)
- New products are in a pickup phase in FY '27; meaningful volume contribution expected gradually toward year-end. (Page 14)
- Export volumes, especially in the USA market, are recovering post-duty adjustments, supporting growth. (Page 14)
2 more points from NOCIL's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what NOCIL said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Rs.130 crores capex focused largely on specialty segment, expected to be commissioned by FY '28, aiming to increase specialty product mix from ~15% to 20%. (Page 17)
- Rs.250 crores capex at Dahej for incremental capacity expansion, increasing capacity by roughly 20%, targeting merchant sales. (Page 8 & 17)
- The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. (Page 8)
- Capex largely internally funded through working capital efficiency without current debt borrowing, with bank lines available if needed at repo-linked rates. (Page 18)
2 more points from NOCIL's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what NOCIL said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what NOCIL said on order book & pipeline — free account, 30 seconds.
NOCIL — Quarterly revenue & net profit
NOCIL Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 330 | 340 | -2.9% | 316 | +4.4% |
| Operating profit (EBITDA) | 21 | 34 | -38.2% | 27 | -22.2% |
| Operating margin | 6% | 10% | -4 pp | 8% | -2 pp |
| Profit before tax | 21 | 26 | -19.2% | 13 | +61.5% |
| Net profit (PAT) | 17 | 21 | -19% | 9 | +88.9% |
| EPS (₹) | 1.02 | 1.24 | -17.7% | 0.55 | +85.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹427 Cr, net profit ₹24 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What NOCIL's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
NOCIL and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were NOCIL Q4 FY26 results?
NOCIL targets double-digit volume growth for FY '27 and FY '28. NOCIL targets double-digit volume growth for FY '27 and FY '28.
What is NOCIL share price analysis?
NOCIL currently shows a neutral. The stock trades at a P/E of 40.1 with a market cap of ₹2,790 Cr. Investors should review the full earnings analysis for detailed insights.
Is NOCIL planning capital expenditure?
Rs.130 crores capex focused largely on specialty segment, expected to be commissioned by FY '28, aiming to increase specialty product mix from ~15% to 20%.
Keep NOCIL on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
